In SMA patients, the SMN2 gene is the only source of SMN protein, and the number of its copies correlates with disease severity, which makes SMN2 the main modifier of spinal muscular atrophy [3]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.